In GBM, the poor outcome related to NDTMM and was enriched in myeloid leukocyte activation, TNF signaling pathway, PDGFRB pathway, ROS, and RNS production in phagocytes (Figure 4H). The gene discussed is PDGFRB; the disease is glioblastoma.